HIV Medication Access Act

This bill amends the Foreign Assistance Act to prioritize HIV prevention and treatment in U.S. international aid programs. It specifically adds assistance for HIV pre-exposure prophylaxis (PrEP) medications to the list of covered activities and reclassifies certain HIV prevention efforts as "core life-saving humanitarian assistance." This change ensures U.S. foreign aid funding for HIV prevention, including PrEP, is treated with the same priority as other essential humanitarian programs. The bill directly affects U.S. foreign aid programs targeting HIV/AIDS prevention and treatment in partner countries.